N/A
Manufactured by Ferring Pharmaceuticals Inc.
5,690 FDA adverse event reports analyzed
Last updated: 2026-04-15
DESMOPRESSIN ACETATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Ferring Pharmaceuticals Inc.. The most commonly reported adverse reactions for DESMOPRESSIN ACETATE include HYPONATRAEMIA, DRUG INEFFECTIVE, HEADACHE, NAUSEA, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DESMOPRESSIN ACETATE.
Out of 3,194 classified reports for DESMOPRESSIN ACETATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 5,690 FDA FAERS reports that mention DESMOPRESSIN ACETATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HYPONATRAEMIA, DRUG INEFFECTIVE, HEADACHE, NAUSEA, FATIGUE, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Ferring Pharmaceuticals Inc. in connection with DESMOPRESSIN ACETATE. Always verify the specific product and NDC with your pharmacist.